Expression of renal 11β-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function

被引:40
|
作者
Quinkler, M
Zehnder, D
Lepenies, J
Petrelli, MD
Moore, JS
Hughes, SV
Cockwell, P
Hewison, M
Stewart, PM [1 ]
机构
[1] Univ Birmingham, Sch Med, Div Med Sci, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Med, Dept Nephrol, Queen Elizabeth Hosp, Birmingham B15 2TT, W Midlands, England
[3] Charite Univ Med Belin, Div Clin Endocrinol, Berlin, Germany
关键词
D O I
10.1530/eje.1.01954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Renal 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) enables selective access of aldosterone to the mineralocorticoid receptor (MR). Impaired 11 beta-HSD2 activity has been suggested in patients with hypertension as well as in patients with renal disease, where it may contribute to sodium retention, oedema and hypertension. To date, these studies have relied upon urinary cortisol (F) metabolite levels as surrogate markers of renal 11 beta-HSU2 activity. Methods: We have directly analysed renal 11 beta-HSD2 mRNA expression in 95 patients undergoing kidney biopsy using TaqMan real-time PCR. Serum and 24-h urine samples were used to document underlying renal function and endocrine parameters. Urinary F and cortisone (E) metabolites were analysed using gas chromatography/mass spectrometry. Results: Expression of 11 beta-HSD2 did not correlate with blood pressure or urinary Na/K ratio, but a significant positive correlation with creatinine clearance was observed (r = 0.284; P < 0.01). Immunofluorescence and confocal laser microscopy confirmed decreased 11 beta-HSD2 expression in patients with impaired renal function. For the first time, we showed that 11 beta-HSD2 mRNA expression correlated negatively with the urinary free (UF) F/E (UFF/UFE) ratio (r = 0.276; P < 0.05) as well as with the urinary tetrahydrocortisol + 5 alpha-tetrahydrocortisol/tetrahydrocortisone ((THF + alpha THF)/THE) ratio (r = 0.256; P < 0.05). No difference in 11 beta-HSD2 mRNA expression or in the UFF/UFE ratio was found between groups with no proteinuria, microalbummuria, moderate or severe proteinuria. In contrast, the urinary (THF + alpha THF)/THE ratio increased significantly (P < 0.05) in patients with severe albuminuria, suggesting increased hepatic 11 beta-HSD1 in those patients. Conclusions: These data suggest that renal 11 beta-HSD2 expression may be represented only marginally better, if at all, by the UFF/UFE than by the (THF + alpha THF)/THE ratio. Reduced renal 11 beta-HSD2 expression may lead to occupancy of the MR by glucocorticoids such as cortisol and may contribute to the increased sodium retention seen in patients with impaired renal function.
引用
收藏
页码:291 / 299
页数:9
相关论文
共 50 条
  • [21] 11 beta Hydroxysteroid Dehydrogenase Type 2 is a Key Component of Neoangiogenesis in Renal Carcinoma and Glioma
    Galbraith, S.
    Gallacher, M.
    Smith, C.
    Christie, L.
    Fleming, S.
    JOURNAL OF PATHOLOGY, 2011, 224 : S33 - S33
  • [22] Adrenal gland involvement in the regulation of renal 11β-hydroxysteroid dehydrogenase 2
    Zallocchi, ML
    Matkovic, L
    Calvo, JC
    Damasco, MC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (03) : 591 - 602
  • [23] Epigenetic regulation of 11β-hydroxysteroid dehydrogenase type 2 expression
    Alikhani-Koopaei, R
    Fouladkou, F
    Frey, FJ
    Frey, BM
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08): : 1146 - 1157
  • [24] Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat
    Tang, Justin I.
    Kenyon, Chris J.
    Seckl, Jonathan R.
    Nyirenda, Moffat J.
    JOURNAL OF HYPERTENSION, 2011, 29 (02) : 282 - 289
  • [25] Activity of renal 11βhydroxysteroid dehydrogenase 2 (11βHSD2) in stressed animals
    Igarreta, P
    Calvo, JC
    Damasco, MC
    LIFE SCIENCES, 1999, 64 (24) : 2285 - 2290
  • [26] Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
    Ekinci, Elif I.
    Jerums, George
    Skene, Alison
    Crammer, Paul
    Power, David
    Cheong, Karey Y.
    Panagiotopoulos, Sianna
    McNeil, Karen
    Baker, Scott T.
    Fioretto, Paola
    MacIsaac, Richard J.
    DIABETES CARE, 2013, 36 (11) : 3620 - 3626
  • [27] Reduced Expression of 11β-Hydroxysteroid Dehydrogenase Type 2 in Preeclamptic Placentas Is Associated With Decreased PPARγ but Increased PPARα Expression
    He, Ping
    Chen, Zhaoguang
    Sun, Qianqian
    Li, Yuan
    Gu, Hang
    Ni, Xin
    ENDOCRINOLOGY, 2014, 155 (01) : 299 - 309
  • [28] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in renal cell neoplasms:: A tissue microarray study
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Leehpammer, M.
    Wang, L. J.
    Sabo, E.
    DeLellis, R. A.
    Resnick, M. B.
    LABORATORY INVESTIGATION, 2007, 87 : 184A - 184A
  • [29] Expression of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in renal cell neoplasms:: A tissue microarray study
    Yakirevich, E.
    Morris, D. J.
    Tavares, R.
    Lechpammer, M.
    Wang, L. J.
    Sabo, E.
    DeLellis, R. A.
    Resnick, M. B.
    MODERN PATHOLOGY, 2007, 20 : 184A - 184A
  • [30] Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function
    Kostner, KM
    Clodi, M
    Bodlaj, G
    Watschinger, B
    Hörl, W
    Derfler, K
    Huber, K
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1998, 28 (06) : 447 - 452